Related content

A Multinational, Multicentre, Non-blinded, Randomized Study of Moxifloxacin Oral Tablets Compared with Co-amoxiclav Oral Tablets in the Treatment of Acute Exacerbation of Chronic Bronchitis

By Schaberg T   Ballin I   Huchon G   Bassaris H   Hampel B   Reimnitz P    

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 314-328

Field House Publishing

Access to resources Recommend Favorite

Rapid Resolution of Symptoms with Moxifloxacin Therapy in 7223 Patients with Acute Exacerbation of Chronic Bronchitis: Comparison with Prior Macrolide Treatment

By Bauer T.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 641-651

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

By Pea Federico  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 287-295

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of 5- vs 10-Day Cefixime Therapy in Acute Exacerbations of Chronic Bronchitis

By Lorenz J.  

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in 2338 Patients with Acute Exacerbation of Chronic Bronchitis

By Barth J.  

Clinical Drug Investigation, Vol. 23, Iss. 1, 2003-01 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite